These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4330843)

  • 1. [Sensitizing properties of purified concentrated Cl. perfringens toxoids].
    Kalinichenko NF; Starobinets ZG; Podgornaia LG; Biriukova SV
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Oct; 48(10):113-5. PubMed ID: 4330843
    [No Abstract]   [Full Text] [Related]  

  • 2. [Characteristics of the immunologic response of animals to Clostridium perfringens anatoxin].
    Petrov RV; Shemanova GF; Panteleev EI; Dmitrieva LN; Vlasova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1977 May; (5):71-4. PubMed ID: 197752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study on the immunogenic properties of Clostridium perfringens type A toxoid.
    Shemanova GF; Vlasova EV; Dmitrieva LN; Trapezov EV; Gorbacheva LD
    J Hyg Epidemiol Microbiol Immunol; 1986; 30(3):323-9. PubMed ID: 2877025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunogenic properties of Clostridium perfringens type A anatheta-hemolysin].
    Sergeeva TI; Dolgikh MS; Blagoveshchenskiĭ VA
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Nov; (11):71-5. PubMed ID: 6275640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunogenicity and thymus-dependence of the polymerized alpha-toxoid of Clostridium perfringens].
    Petrov RV; Shemanova GF; Kaverzneva ED; Kissel' VL; Panteleev EI
    Biull Eksp Biol Med; 1977 Dec; 84(12):695-8. PubMed ID: 202354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Factors modulating production of antibodies against Clostridium perfringens in mammals].
    Shemanova GF; Sergeeva TI; Panteleev EI; Vlasova EV; Dmitrieva LN
    Biull Eksp Biol Med; 1981 Sep; 92(9):322-5. PubMed ID: 6271303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of the interrelationship between the content of immunizing units and the immunogenicity of C1. perfringens anatoxins].
    Nenashev VP; Akhundova KA
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Aug; (8):93-6. PubMed ID: 173119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A comparative study of the antigenic and immunogenic properties of the anatoxin of Cl. perfringens, concentrated and purified by various methods].
    Larina IA; Samsonova VS; Volkova ZM
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Apr; 45(4):86-9. PubMed ID: 4309741
    [No Abstract]   [Full Text] [Related]  

  • 9. [Preparation and evaluation of immunogenic properties of Clostridium perfringens type A toxoid].
    Rymkiewicz D; Sawicki J; Brühl A; Sochańska R
    Med Dosw Mikrobiol; 1979; 31(2):95-102. PubMed ID: 228130
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunochemical study of the enzymes of a toxic complex of Cl. perfringens].
    Ispolatovskaia MV; Klimacheva LV; Tokinova TN; Larina IA
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Apr; 48(4):89-93. PubMed ID: 4327165
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of humoral neutralizing antibody response in rabbits, guinea pigs, and cattle vaccinated with epsilon and beta toxoids from Clostridium perfringens and C. botulinum types C and D toxoids.
    Silva ROS; Duarte MC; Oliveira Junior CA; de Assis RA; Lana AMQ; Lobato FCF
    Anaerobe; 2018 Dec; 54():19-22. PubMed ID: 30076896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The detection of the factor lowering the immunogenicity of toxoid of Clostridium perfringens type A.
    Shemanova GF; Vlasova EV; Sergeeva TI; Panteleyev EI
    Arch Roum Pathol Exp Microbiol; 1981; 40(4):299-303. PubMed ID: 6280638
    [No Abstract]   [Full Text] [Related]  

  • 13. Alpha toxoid of Clostridium perfringens. II. Immunogenicity of the toxoid.
    Ito A
    Jpn J Med Sci Biol; 1970 Feb; 23(1):21-30. PubMed ID: 4317538
    [No Abstract]   [Full Text] [Related]  

  • 14. [The functional activity of wound mononuclear phagocytosing cells in revaccination with a Clostridium perfringens anatoxin].
    Sergeeva TI; Zaĭtseva LG; Chirikova EV; Vasil'eva EI; Babaĭtseva VA; Kornienko OIu
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):63-5. PubMed ID: 7879544
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of potential protective immunity against enterotoxemia in calves by single or multiple recombinant Clostridium perfringens toxoids.
    Jiang Z; De Y; Chang J; Wang F; Yu L
    Microbiol Immunol; 2014 Nov; 58(11):621-7. PubMed ID: 25197030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte reactivity to Clostridium perfringens antigens and toxoid in patients with arthritis.
    Ström H; Johansson Borg A; Nord CE; Olhagen B; Möller E
    Br J Rheumatol; 1995 Nov; 34(11):1095-6. PubMed ID: 8542216
    [No Abstract]   [Full Text] [Related]  

  • 17. The titration of clostridial toxoids and antisera in cell culture.
    Knight PA; Burnett C; Whitaker AM; Queminet J
    Dev Biol Stand; 1986; 64():129-36. PubMed ID: 2878845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Protective properties of theta-hemolysin obtained by affinity chromatography].
    Efimova MG; Blagoveshchenskiĭ VA; Khatuntseva BV
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Dec; (12):87-92. PubMed ID: 6297191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development, preparation and safety testing of a Clostridium welchii type C toxoid. I: preliminary observations in man in Papua New Guinea.
    Walker PD; Foster WH; Knight PA; Freestone DS; Lawrence G
    J Biol Stand; 1979; 7(4):315-23. PubMed ID: 231605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physico-chemical and immunobiological properties of the ribosomal preparations of Clostridium perfringens, type A].
    Efimova MG
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (2):46-9. PubMed ID: 9662798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.